The Practitioner - 1868-2020: Supporting general practitioners for more than 150 years - Weighing up the risks and benefits of smoking cessation therapies

Other sections

Site Tools

ARTICLE KEY

= Registered users

= Paid-up subscribers

Special Interest

Bland P. Weighing up the risks and benefits of smoking cessation therapies. Practitioner 2013; 257 (1766):5

Weighing up the risks and benefits of smoking cessation therapies

05 Dec 2013 Pais-up subscribers

A prospective cohort study from the UK has found no evidence that varenicline or bupropion raise the risk of depression, self harm or suicide.

Paid-up subscribers This article can be accessed only if you are a paid-up subscriber to The Practitioner.